Vitamin K Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement
Conditions:   AORTIC VALVE DISEASES;   Thromboembolism Interventions:   Drug: Apixaban Oral Tablet;   Drug: Vitamin K antagonist(warfarin) Sponsor:   Joon Bum Kim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2020 Category: Research Source Type: clinical trials

Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.
Condition:   Atrial Fibrillation (AF) Interventions:   Drug: BAY2433334;   Drug: Apixaban;   Other: BAY2433334 matching placebo;   Other: Apixaban matching placebo Sponsor:   Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 6, 2020 Category: Research Source Type: clinical trials